6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride
C24H24Cl2FN3O — CID 153366220
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride
6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride (PubChem CID 153366220) has the molecular formula C24H24Cl2FN3O and a molecular weight of 460.38 g/mol. Its IUPAC name is 6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride.
Molecular Properties
| Compound Name | 6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride |
|---|---|
| PubChem CID | 153366220 |
| Molecular Formula | C24H24Cl2FN3O |
| Molecular Weight | 460.38 g/mol |
| Exact Mass | 459.13 |
| IUPAC Name | 6-chloro-2-[1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]-1H-indazol-3-one;hydrochloride |
| SMILES | CC(C1CCC(c2ccnc3ccc(F)cc23)CC1)n1[nH]c2cc(Cl)ccc2c1=O.Cl |
| InChI | InChI=1S/C24H23ClFN3O.ClH/c1-14(29-24(30)20-8-6-17(25)12-23(20)28-29)15-2-4-16(5-3-15)19-10-11-27-22-9-7-18(26)13-21(19)22;/h6-16,28H,2-5H2,1H3;1H |
| InChIKey | WSDXGTQKTHXYSC-UHFFFAOYSA-N |
| XLogP | 6.63 |
| TPSA | 50.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 460.38 |
| LogP ≤ 5 | 6.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het_65_B(7)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153366220 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.